Chemical Compound
(2R,3S,4S,5R,6R)-2-{[(2R,3S,4S,5S,6S)-2-[(1R,2S)-2-({6-amino-2-[(1S)-1-{[(2S)-2-amino-2-carbamoylethyl]amino}-2-carbamoylethyl]-5-methylpyrimidin-4-yl}formamido)-2-{[(2R,3S)-4-{[(1S,2R)-1-[(1-{[(2S,3R,4R,5S,6S)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-2-{4-[4-({3-[(4-aminobutyl)amino]propyl}carbamoyl)-1,3-thiazol-2-yl]-1,3-thiazol-2-yl}-2-hydroxyethyl)carbamoyl]-2-hydroxypropyl]carbamoyl}-3-hydroxybutan-2-yl]carbamoyl}-1-(1H-imidazol-4-yl)ethoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl carbamate
CAS Registry Number
65057-91-2
Primary record
(2R,3S,4S,5R,6R)-2-{[(2R,3S,4S,5S,6S)-2-[(1R,2S)-2-({6-amino-2-[(1S)-1-{[(2S)-2-amino-2-carbamoylethyl]amino}-2-carbamoylethyl]-5-methylpyrimidin-4-yl}formamido)-2-{[(2R,3S)-4-{[(1S,2R)-1-[(1-{[(2S,3R,4R,5S,6S)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-2-{4-[4-({3-[(4-aminobutyl)amino]propyl}carbamoyl)-1,3-thiazol-2-yl]-1,3-thiazol-2-yl}-2-hydroxyethyl)carbamoyl]-2-hydroxypropyl]carbamoyl}-3-hydroxybutan-2-yl]carbamoyl}-1-(1H-imidazol-4-yl)ethoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl carbamate
- 库存
- 9,354 克
- 纯度
- 98.3 %
- CAS
- 65057-91-2
化合物标识与属性
- CAS
- 65057-91-2
- PubChem CID
- 102059865
- SMILES
- C[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)OC(C(C2=NC(=CS2)C3=NC(=CS3)C(=O)NCCCNCCCCN)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)C[C@@H]([C@@H](C)NC(=O)[C@H]([C@H](C4=CN=CN4)O[C@H]5[C@H]([C@H]([C@@H]([C@@H](O5)CO)O)O)O[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)CO)O)OC(=O)N)O)NC(=O)C7=C(C(=NC(=N7)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)N)C)O)O)O)N
- Canonical SMILES
- Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)CC(=O)N[C@H](C(=O)NC(O[C@@H]1O[C@@H](C)[C@@H](N)[C@@H](O)[C@H]1O)C(O)c1nc(-c2nc(C(=O)NCCCNCCCCN)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1cnc[nH]1
名称与同义词
- Tallysomycin B
- Talisomycin B
- Antibiotic BU 2231B
- Antibiotic BU-2231B
- BU-2231B
- UNII-17LR410D8A
- TALLYSOMYCIN B [MI]
- 17LR410D8A
- C62H98N20O26S2
- J34.313G
- C62-H98-N20-O26-S2
- 65057-91-2
- (2R,3S,4S,5R,6R)-2-{[(2R,3S,4S,5S,6S)-2-[(1R,2S)-2-({6-amino-2-[(1S)-1-{[(2S)-2-amino-2-carbamoylethyl]amino}-2-carbamoylethyl]-5-methylpyrimidin-4-yl}formamido)-2-{[(2R,3S)-4-{[(1S,2R)-1-[(1-{[(2S,3R,4R,5S,6S)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-2-{4-[4-({3-[(4-aminobutyl)amino]propyl}carbamoyl)-1,3-thiazol-2-yl]-1,3-thiazol-2-yl}-2-hydroxyethyl)carbamoyl]-2-hydroxypropyl]carbamoyl}-3-hydroxybutan-2-yl]carbamoyl}-1-(1H-imidazol-4-yl)ethoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl carbamate
- Bleomycinamide, N(sup 1)-(3-((4-aminobutyl)amino)propyl)-13-((4-amino-4,6-dideoxy-alpha-L-talopyranosyl)oxy)-19-demethyl-12-hydroxy-
- BLEOMYCINAMIDE, N1-(3-((4-AMINOBUTYL)AMINO)PROPYL)-13-((4-AMINO-4,6-DIDEOXY-.ALPHA.-L-TALOPYRANOSYL)OXY)-19-DEMETHYL-12-HYDROXY-
- N1-(3-((4-AMINOBUTYL)AMINO)PROPYL)-13-((4-AMINO-4,6-DIDEOXY-.ALPHA. -L-TALOPYRANOSYL)OXY)-19-DEMETHYL-12-HYDROXYBLEOMYCINAMIDE
- N1-[3-[(4-Aminobutyl)amino]propyl]-13-[(4-amino-4,6-dideoxy-alpha-L-talopyranosyl)oxy]-19-demethyl-12-hydroxybleomycinamide